Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
2008
Anti-HIV Activity of Novel Isatine-Sulphonamides
publication
Evidence: moderate
Author Information
Author(s): Selvam P., Murugesh N., Chandramohan M., Debyser Z., Witvrouw M.
Primary Institution: Arulmigu Kalasalingam College of Pharmacy
Hypothesis
The study investigates the anti-HIV activity of synthesized isatine-sulphonamide derivatives.
Conclusion
Some isatine-sulphonamide derivatives showed significant inhibitory effects against HIV-1 replication.
Supporting Evidence
- 4-(1-acetyl-5-methyl-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide inhibits HIV Integrase enzymatic activity.
- 4-(1-benzoyl-5-chloro-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide exhibits 36 percent maximum protection against HIV-1.
- None of the compounds exhibited anti-HIV effect and all displayed cytotoxic properties in MT-4 cells.
Takeaway
The researchers made new compounds and found that some can help fight HIV, but they also found that these compounds can be harmful to cells.
Methodology
The compounds were synthesized and tested for anti-HIV activity in MT-4 cells using various assays.
Limitations
The compounds exhibited cytotoxic properties in the lymphocyte cell line (MT-4 cells).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website